samedan logo

 
 
spacer
home > ebr > winter 2003 > e-meetings and e-learning - how the internet can be harnessed to achieve efficiencies in clinical drug development
PUBLICATIONS
European Biopharmaceutical Review

e-Meetings and e-Learning - How the Internet can be Harnessed to Achieve Efficiencies in Clinical Drug Development

Driven by a need to reduce drug development costs and speed new drugs to market in the most efficient manner possible, today's pharma industry is awash with cost containment measures. Senior executives continue the search for elusive efficiencies, ranging from the overnight closure of departments that were previously considered integral to a company's success to the imposition of strict new travel policies. Few pharmaceutical companies or contract research organisations can have been immune to cost cutting in recent years and many have looked to the promise of technology to help them achieve their goals.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Jane Baguley, Director at Cornaxis Ltd

With an Honours degree in Cell Sciences, Jane Baguley joined the pharmaceutical industry in 1988. After five years with Yamanouchi Pharma, Jane began a varied career at Quintiles encompassing both operational and business roles including clinical project management, medical writing, communication and strategy and business management. At the beginning of 2002, Jane set up Cornaxis Ltd to provide consultancy, strategic and operational services to the pharma industry. Cornaxis focuses on the use of novel technologies to support the attainment of cost efficiencies in the drug development process, while Jane maintains a particular interest in the challenge of patient recruitment.

spacer
Jane Baguley
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Signant Health Partners with Propeller Health to Gather Accurate Data on Asthma and COPD Medication Use

Philadelphia, PA – January 07, 2020: Signant Health announced today a partnership to connect TrialMax®, the industry-leading electronic Clinical Outcome Assessment (eCOA) platform, to Propeller Health’s digital health platform for asthma and COPD (chronic obstructive pulmonary disease).
More info >>

White Papers

Orthogonal Approaches for the Analysis of Protein Sequence

Ludger Ltd

One of the most important classes of biopharmaceuticals is monoclonal antibodies. They are expressed from living cells, and are consequently subject to complex biochemical pathways. Not all of these routes are fully understood, and many are sensitive to the subtlest of environmental changes. Changes such as these can affect the final biopharmaceutical sequence, structure and post-translational modifications, not to mention any changes that may occur during further purification. This often means that the final product from one batch may be different from the last in another batch. Each batch is a complicated mix of similar molecules, and analysis of the degree of batch-to-batch variation is therefore very important to the establishment of the drug's safety for medicinal use and patient administration.
More info >>

 
Industry Events

2020 Avoca Quality and Innovation Summit

3-4 June 2020, Amsterdam, The Netherlands

The 2020 Avoca Quality and Innovation Summit will take place 3-4 June 2020, in Amsterdam, The Netherlands.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement